o. yildiz Et Al. , "Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive HCV genotype 1b patient," 25 th Annual Conference of Asian Pacific Association for the Study of the Liver , 2016
yildiz, o. Et Al. 2016. Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive HCV genotype 1b patient. 25 th Annual Conference of Asian Pacific Association for the Study of the Liver .
yildiz, o., AYGEN, B., türe, Z., baltaci, s., & ALABAY, S., (2016). Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive HCV genotype 1b patient . 25 th Annual Conference of Asian Pacific Association for the Study of the Liver
yildiz, orhan Et Al. "Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive HCV genotype 1b patient," 25 th Annual Conference of Asian Pacific Association for the Study of the Liver, 2016
yildiz, orhan Et Al. "Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive HCV genotype 1b patient." 25 th Annual Conference of Asian Pacific Association for the Study of the Liver , 2016
yildiz, o. Et Al. (2016) . "Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive HCV genotype 1b patient." 25 th Annual Conference of Asian Pacific Association for the Study of the Liver .
@conferencepaper{conferencepaper, author={orhan yildiz Et Al. }, title={Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive HCV genotype 1b patient}, congress name={25 th Annual Conference of Asian Pacific Association for the Study of the Liver}, city={}, country={}, year={2016}}